// App-Quantinova.ai

P146 : Initial response to induction treatment more important than type of induction treatment for achieving sustained steroid free remission at 1 year in new-onset paediatric Crohn’s disease

Researchers

Presenter

  • Klomberg, R

Principal Investigators

  • van der Wal, H

  • Sarbagili, C

  • Kemos, P

  • Ruemelle, F

  • Croft, N

  • de Ridder, L

  • Levine, A

Medical Centers

  • Erasmus MC-Sophia Children's Hospital, Pediatric Gastroenterology, Rotterdam, Netherlands

  • PIBD research center- Wolfson Medical Center, Pediatric Gastroenterology Unit, Holon, Israel

  • Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, Paediatric gastroenterology, London, UK

  • Université Paris Descartes- Sorbonne Paris Cité- APHP- Hôpital Necker Enfants Malades, Paediatric Gastroenterology, Paris, France

  • PIBD-SETQ consortiu

Locations

  • Netherlands

  • Israel

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Crohn's disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved